Muscle News and Research

RSS

Agfa HealthCare's IMPAX HeartStation enables rapid diagnosis of 15-lead ECG studies when compared to 12-lead ECG studies at Western Maryland Regional Medical Center

Agfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, today announces that Western Maryland Regional Medical Center's recent upgrade to the newest version of IMPAX HeartStation ECG Management System has helped enable the rapid diagnosis and treatment of patients with posterior wall heart attacks. The Cumberland-based hospital is using the recently released features of IMPAX HeartStation to digitally review and archive 15-lead ECG studies.

22 Jul 2010

Study shows how muscle, fat could play role in survival of heart failure patients

University of Alberta research has discovered heart failure patients with more muscle have the potential to increase their length of life. Antigone Oreopoulos, a researcher from the U of A's School of Public Health, studied 140 patients with heart failure. Study participants underwent a special scan to measure their muscle mass and body fat.

22 Jul 2010

Survey links autism with digestive problems, intestinal inflammation

Autism is the fastest growing developmental disorder in the world. With 1 child in 91 facing the disorder, the diagnosis is more common than pediatric cancer, diabetes, and AIDS combined.

22 Jul 2010

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Fero Industries, Inc. is pleased to provide these comments regarding the recent Food and Drug Administration advisory panel recommendation concerning the GlaxoSmithKline PLC diabetes drug Avandia. The FDA advisory panel has recommended that the agency keep diabetes drug Avandia on the U.S. market despite data clearly showing an increased risk of a heart attack and that GSK covered up their own research that first identified the problem.

20 Jul 2010

Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2

Acorda Therapeutics, Inc. today announced the National Heart, Lung, and Blood Institute has awarded a $1 million Cardiac Translational Research Implementation Program grant to support research on Glial Growth Factor 2, a novel investigational agent for the treatment of patients with heart failure under development at Acorda.

20 Jul 2010

New technique to measure ATP from arterioles helps understand hypertension in women

Research at the University of Arkansas took a step toward understanding hypertension in women by using a new technique to examine the release of a neurotransmitter in small blood vessels.

20 Jul 2010

Lots of water breaks prevent dehydration in kids

Scorching heat has taken its toll across the country this summer with record temperatures and heat indexes reaching well above 100 degrees. Add kids playing outside and outdoor summer activities in full swing to the dangerous heat you've got a hazardous combination.

20 Jul 2010

Study evaluates immunization benefits of dissolving microneedles

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines - while providing improved immunization against diseases such as influenza.

19 Jul 2010

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.

19 Jul 2010

Two-thirds of world's population are vitamin D-insufficient or deficient

Vitamin D surfaces as a news topic every few months. How much daily vitamin D should a person get? Is it possible to have too much of it? Is exposure to the sun, which is the body's natural way of producing vitamin D, the best option? Or do supplements suffice?

16 Jul 2010

FDA confirms GRAS status for Ajinomoto's AjiGRAS-Leucine

Ajinomoto AminoScience LLC (AAS) today announced that it has confirmed GRAS (Generally Recognized As Safe) status of its AjiGRAS-Leucine, meeting the safety standards demanded by the US Food and Drug Administration (FDA). As the only formulation of Leucine currently with FDA acknowledged GRAS status, Ajinomoto's AjiGRAS-Leucine is the first amino acid to be allowed as an ingredient for use in conventional foods like non-milk and milk based meal replacements, sports and isotonic beverages, vitamin enhanced waters, and meal replacement bars, at levels of 0.5 to 3 grams per serving.

16 Jul 2010

ALOKA announces new ProSound F75 high-end color diagnostic ultrasound system

ALOKA CO., LTD., announced on July 16 the ProSound F75, a high-end color diagnostic ultrasound system of the new "F" series at its private exhibition, "Aloka Fair 2010." This new flagship of multi-purpose systems, providing unprecedented performance in a variety of clinical applications, is comfortable and easy to use.

16 Jul 2010

Proteinuria screening identifies risk for kidney disease progression

A morning urine test is superior to all other tests for detecting declining kidney performance in patients with diabetic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that clinicians should monitor kidney function by measuring the albumin:creatinine ratio from a first morning urine sample.

16 Jul 2010

PPMD to provide grant to clinical sites participating in Phase 2 study of ACE-031

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy, the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy, announced that PPMD will provide a grant to clinical sites participating in Acceleron Pharma's Phase 2 clinical study of ACE-031. These grants will help patients' families cover travel costs to and from the study site, and hotel rooms and meals during study visits.

15 Jul 2010

MD Buyline identifies top emerging technologies with highest impact

This release will explain how these important technologies encourage high utilization rates across multiple service lines, bringing value to hospitals. Reimbursement changes and hospital structure enable technology purchases to generate a sequence of changes throughout service lines and dramatically impact the bottom line.

15 Jul 2010

New research focuses on calcium channels in lysosome membrane

In cells, as in cities, disposing of garbage and recycling anything that can be reused is an essential service. In both city and cell, health problems can arise when the process breaks down.

15 Jul 2010

Study reveals anti-diabetic properties of cashew seed extract

Cashew seed extract shows promise as an effective anti-diabetic, according to a new study from the University of Montreal (Canada) and the Universit- de Yaound- (Cameroun). Published in the journal Molecular Nutrition & Food Research, the investigation analyzed the reputed health benefits of cashew tree products on diabetes, notably whether cashew extracts could improve the body's response to its own insulin.

15 Jul 2010

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

Texas Children's Hospital in Houston has performed the hospital's first triple-organ transplant on a 16-year-old Brenham resident. The patient, Taylor Sherrouse, underwent a 13-hour surgery on Tuesday, June 22 to replace her heart, lungs and liver, which had been severely damaged by cystic fibrosis. Taylor is one of only three pediatric patients in the country this decade to receive heart, lungs and liver in one operation.

15 Jul 2010

Medtronic launches educational campaign to promote awareness on spasticity

Medtronic, Inc. today announced the launch of an educational campaign, called Release Your Potential, that is designed to raise awareness of spasticity, a condition that makes it difficult to voluntarily relax muscles.

14 Jul 2010

Research finding could yield new ideas for treating symptoms of motor neurone disease

Scientists in Aberdeen have discovered a mechanism that muscles use to regulate the nerves which control them. They believe their finding could yield new ideas for treating symptoms of motor neurone disease - a progressive and incurable neurodegenerative condition that leads to muscle weakness and wasting - and other neuromuscular conditions.

13 Jul 2010

Muscle News and Research

Agfa HealthCare's IMPAX HeartStation enables rapid diagnosis of 15-lead ECG studies when compared to 12-lead ECG studies at Western Maryland Regional Medical Center

Study shows how muscle, fat could play role in survival of heart failure patients

Survey links autism with digestive problems, intestinal inflammation

Fero Industries provides comments concerning FDA advisory panel recommendation on diabetes drug Avandia

Acorda Therapeutics awarded $1M C-TRIP grant to support research on GGF2

New technique to measure ATP from arterioles helps understand hypertension in women

Lots of water breaks prevent dehydration in kids

Study evaluates immunization benefits of dissolving microneedles

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Two-thirds of world's population are vitamin D-insufficient or deficient

FDA confirms GRAS status for Ajinomoto's AjiGRAS-Leucine

ALOKA announces new ProSound F75 high-end color diagnostic ultrasound system

Proteinuria screening identifies risk for kidney disease progression

PPMD to provide grant to clinical sites participating in Phase 2 study of ACE-031

MD Buyline identifies top emerging technologies with highest impact

New research focuses on calcium channels in lysosome membrane

Study reveals anti-diabetic properties of cashew seed extract

First triple-organ transplantation performed on young Brenham resident at Texas Children's Hospital

Medtronic launches educational campaign to promote awareness on spasticity

Research finding could yield new ideas for treating symptoms of motor neurone disease

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News